AxonPrime, an affiliate of our sponsor, is a partnership between Dinakar Singh and others affiliated with Axon Capital and Dakin Sloss and others affiliated with Prime Movers Lab LLC. AxonPrime unites Axon Capital’s expertise in global investing in public and private equities with Prime Movers Lab’s leading platform for investing in science and deep technology […]

We intend to focus our efforts on businesses that leverage our management team’s experience in acquiring and operating businesses in the consumer industry. We intend to focus our efforts and will seek to capitalize on our founders’ distinctive and complementary backgrounds to identify, acquire and transformatively impact a target business with a substantial portion of […]

We intend to capitalize on the ability of our management team to identify, acquire, and operate a business in the energy industry in North America, though we reserve the right to pursue an acquisition opportunity in any business or industry. We believe that there is a timely opportunity at this unique inflection point in the […]

We intend to concentrate our efforts identifying businesses in the FinTech industry with an enterprise value of approximately $500 million to $1.0 billion, with particular emphasis on businesses that are providing digital, online or mobile payment solutions, processing and gateway services, point-of-sale technology, consumer engagement platforms and ecommerce or loyalty solutions. We believe the creation, delivery […]

We intend to focus our search in the North American and European industrials sector. (Incorporated in the Cayman Islands) We intend to source initial business combination opportunities through our management team’s extensive network of industrials sector business owners, public and private company executives and board members, investment bankers, private equity and debt investors, high net […]

(Note: IPOScoop has NO Call on this micro-cap unit offering. Each unit consists of one share of common stock and one warrant to buy one share of common stock.) We are a clinical biopharmaceutical company whose first product candidate, RenovoGem, is a drug and device combination of intra-arterial gemcitabine and RenovoCath. The FDA has granted […]

(Note: IPOScoop has No Call on this micro-cap IPO. The company changed the IPO’s terms to a unit offering in an S-1/A filing on Aug. 6, 2021, a shift from its initial plans to offer only shares of common stock. Under the amended terms, the company’s stock will trade under the proposed symbol “DRMA” and […]

(Note: This is a unit offering. IPOScoop has NO CALL on this IPO because this is a micro-cap unit offering. The common stock will trade on the NASDAQ under the proposed symbol “DATS” and the warrants under the proposed symbol “DATSW”. Each unit consists of one share of our common stock and one Series A […]

We intend to focus on consumer-facing companies with a significant Africa presence or a compelling Africa potential, which complements the expertise of our management team. (Incorporated in Delaware) Marcus Choo Yeow Ngoh is our CEO. He has over 15 years of experience in the business and entrepreneurship world, building great consumer products and companies. His accomplished […]

AfterNext is a special purpose acquisition company that we created to acquire an innovative company that seeks access to the public financial markets and the intellectual capital of our team to help propel and accelerate the adoption of technologies across healthcare in the new HealthTech arena. (Incorporated in the Cayman Islands)